CRC Clinical Trial
Official title:
Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy
Verified date | March 2017 |
Source | Motus GI Medical Technologies Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Motus Gl is developing a single-use device that attaches to a standard colonoscope, thereby
integrating colon cleansing, screening and treatment into one procedure.
The device creates turbulence within the colon using water jets. The colon's fecal fluids are
evacuated by the system.
Status | Completed |
Enrollment | 71 |
Est. completion date | October 2013 |
Est. primary completion date | October 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 69 Years |
Eligibility |
Inclusion Criteria: - Subjects in the age range of 50-69 years - Subjects who are considered for routine screening colonoscopy - Subjects with BMI within the range of 18.5-30 - Subject is willing to sign informed consent form Exclusion Criteria: - History of G diseases or history of Colorectal cancer (personal or family) - Previous major abdominal surgeries - Medical status ASA grater or equal to 3 - Acute Gl symptoms, such as bleeding, unexplained weight loss, inflammatory bowel disease (lBD). - Patients taking anticoagulants (e.g., Coumadin, Heparin, Clopidrogrel) - Life-threatening condition - Subjects who are unable or unwilling to cooperate with study procedures - Severe Diverticula |
Country | Name | City | State |
---|---|---|---|
Spain | Clinica San Rafael | Cadiz |
Lead Sponsor | Collaborator |
---|---|
Motus GI Medical Technologies Ltd |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean Score of Boston Bowel Preparation Scale (BBPS) Index Prior and After the Use of MotusGI CleanUp System | Human colon has 3 segments and each segment can be scored 0 (unprepared colon) - 3 (clean colon). average of all colon segments BBPS score after the use of MotusGI CleanUp System | during colonoscopy procedure after cleansing with CleanUp System |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05002270 -
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
|
Phase 1/Phase 2 | |
Recruiting |
NCT04557449 -
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04981119 -
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
|
||
Active, not recruiting |
NCT01308086 -
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04585035 -
Study to Evaluate D-1553 in Subjects With Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03665285 -
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03336658 -
Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer
|
||
Recruiting |
NCT06445062 -
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03875313 -
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT05382377 -
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
|
Early Phase 1 | |
Active, not recruiting |
NCT05314309 -
Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
|
||
Recruiting |
NCT06259552 -
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
|
Phase 1 | |
Completed |
NCT05976282 -
Addressing Colorectal Cancer in South Florida Firefighters
|
N/A | |
Recruiting |
NCT01593098 -
A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)
|
||
Recruiting |
NCT03597581 -
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
|
Phase 1 | |
Terminated |
NCT05368688 -
Microbiome in Colorectal Cancer Onset and Progression
|
||
Completed |
NCT03965845 -
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06455254 -
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
|
Phase 2 | |
Not yet recruiting |
NCT03601598 -
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04868773 -
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
|
Phase 1 |